Can Buying CRISPR Therapeutics and Holding It Forever Make You a Millionaire?
It's been a long journey for CRISPR Therapeutics, which went public in 2016 and has declined over 80% from its 2021 peak. But now, the business could finally be nearing liftoff. Can buying today and holding it forever make you a millionaire? The first steps of commercialization, and what's next The company has shown its revolutionary technology can deliver life-changing therapies. Now, it's about whether CRISPR Therapeutics can replicate the success across its promising pipeline. Our genetics are like natur ...